Personal stories encourage donors to open wallets.American Cancer Society The American Cancer Society (ACS) has invested $ 5 billion in research, but you won’t see that statistic in its new print and TV ads. Thanks in large part to the ACS, the nation has seen a 26% reduction in cancer rates since the early 1990s.… Read More »
Cancer screening programmes are to be reviewed following high-profile mistakes that have put thousands of patients in England at risk. NHS England has asked former government cancer tsar Sir Mike Richards to look at what changes are needed. Three national schemes cover breast, cervical and bowel cancers. On Wednesday, it emerged letters about the cervical… Read More »
DNA from tumours could reveal cancers earlier Medicshots / Alamy By Alice Klein A simple blood test can detect eight different types of cancer. It does this by detecting the various sizes of tumour DNA fragments that flow through the body. At the moment, most cancer screening tools are limited to specific areas of the body –… Read More »
Women who like to wake up earlier have nearly half the risk of breast cancer as their night owl counterparts, according to a study presented by British scientists on Tuesday. Researchers at University of Bristol found that women who are “morning people” are 40 to 48 percent less likely to develop breast cancer than women… Read More »
It was September 2007 when 37-year-old Stephanie Hosford discovered a chickpea-sized lump. (iStock) She didn’t know it yet, but finding a lump in her breast was just the first in a series of life-altering events. It was September 2007 when 37-year-old Stephanie Hosford discovered that chickpea-sized lump. At the time, she and her husband, Grant,… Read More »
FDA Approves Lorbrena (lorlatinib) for Previously-Treated ALK-Positive Metastatic Non-Small Cell Lung Cancer Print this page November 2, 2018 Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved Lorbrena [lor-BREN-ah] (lorlatinib), a third-generation anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitor (TKI) for patients with ALK-positive metastatic non-small cell lung cancer… Read More »